Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.

OBJECTIVE The purpose of our study was to determine whether unenhanced CT attenuation value, enhanced CT attenuation value, or lesion size can be used to differentiate adrenal adenomas from nonadenomatous adrenal masses. MATERIALS AND METHODS We retrospectively assessed the CT scans of 135 adrenal masses in 124 patients with a variety of adrenal masses. There were 93 cortical adenomas (85 nonhyperfunctioning adenomas, four Cushing's adenomas, and four primary aldosteronism adenomas). The nonadenomas consisted of 34 metastases, four cortical carcinomas, and four pheochromocytomas. The scattergrams and mean values of the size and attenuation values on enhanced and unenhanced scans were correlated with the final diagnoses. Results were also subjected to receiver operating characteristic analysis. RESULTS Forty-one adenomas and 20 nonadenomas had unenhanced CT. The mean attenuation value of the 41 adenomas was significantly lower (p < .001) than that of the nonadenomas (2.5 H +/- 14 compared with 32 H +/- 6.4). The lowest unenhanced CT attenuation value of the nonadenomas was 18 H; therefore, the sensitivity:specificity ratio for the diagnosis of adenomas was 85%:100% at a threshold value of 18 H. At this threshold, the positive predictive value was 100% and the negative predictive value was 77%. For the 85 masses with enhanced CT, the mean attenuation of the 60 adenomas was also significantly lower (p < .01) than for the 25 nonadenomas (47 H +/- 24 compared with 62 H +/- 21). The lowest enhanced CT attenuation value of the nonadenomas was also 18 H, but the sensitivity:specificity ratio was only 10%:100% at this threshold value of 18 H. Although the mean diameter of the adenomas was significantly lower (p < .001) than for the nonadenomas (2.4 cm +/- 0.9 compared with 4.5 cm +/- 2.5), there was sufficient overlap between the two groups at the smallest sizes that a threshold value for a highly specific diagnosis of adenoma was not present. The area under the receiver operating characteristic curve for unenhanced CT attenuation values (0.98 +/- 0.02) was significantly greater than the area for enhanced CT values (0.68 +/- 0.06, p < .001) and the area for size (0.79 +/- 0.04, p < .001). CONCLUSIONS Unenhanced CT attenuation values can characterize an adrenal mass as a benign adenoma with high specificity and acceptable sensitivity. Adrenal masses cannot be characterized using enhanced CT attenuation values or lesion size.

[1]  J. Gill,et al.  Adrenal Cortical Tumors with Low Attenuation Coefficients: A Pitfall in Computed Tomography Diagnosis , 1978, Journal of computer assisted tomography.

[2]  S. Swensen,et al.  Percutaneous adrenal biopsy: review of a 10-year experience. , 1994, Radiology.

[3]  A. Megibow,et al.  Non-functioning adrenal adenomas discovered incidentally on computed tomography. , 1983, Radiology.

[4]  B. Naylor,et al.  Adrenal masses in oncologic patients: functional and morphologic evaluation. , 1988, Radiology.

[5]  T. Egglin,et al.  Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. , 1991, Radiology.

[6]  H. Miyake,et al.  CT of adrenal tumors: frequency and clinical significance of low-attenuation lesions. , 1989, AJR. American journal of roentgenology.

[7]  D. Mitchell,et al.  Benign adrenocortical masses: diagnosis with chemical shift MR imaging. , 1992, Radiology.

[8]  V. M. Phillips,et al.  CT-guided adrenal biopsy: accuracy, safety, and indications. , 1985, AJR. American journal of roentgenology.

[9]  Amy S. Tidwell,et al.  Imaging of adrenal gland disorders. , 1997, The Veterinary clinics of North America. Small animal practice.

[10]  N. Obuchowski,et al.  Metastasis or adenoma? Computed tomographic evaluation of the adrenal mass. , 1994, Cleveland Clinic journal of medicine.

[11]  J. Reinig MR imaging differentiation of adrenal masses: has the time finally come? , 1992, Radiology.

[12]  E. Kazerooni,et al.  Percutaneous CT‐Guided Biopsy of Adrenal Masses: Immediate and Delayed Complications , 1995, Journal of computer assisted tomography.

[13]  J. Bloem,et al.  CT and MR Distinction of Adenomas and Nonadenomas of the Adrenal Gland , 1994, Journal of computer assisted tomography.

[14]  A. Novick,et al.  Cleveland Clinic experience with adrenal Cushing's syndrome. , 1997, The Journal of urology.

[15]  C. Metz ROC Methodology in Radiologic Imaging , 1986, Investigative radiology.

[16]  S. Seltzer,et al.  Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies. , 1993, Radiology.

[17]  R. Levitt,et al.  Nonfunctioning adrenal masses: incidental discovery on computed tomography. , 1982, AJR. American journal of roentgenology.

[18]  M. Uder,et al.  Indikationen zur Operation bei asymptomatischen Nebennierentumoren , 1997 .

[19]  Thompson Wr,et al.  Adenocarcinoma metastatic to the adrenal gland simulating myelolipoma: CT evaluation , 1985 .

[20]  C. Caldwell,et al.  Differentiation of adrenal masses with MR imaging: comparison of techniques. , 1994, Radiology.

[21]  I. Francis,et al.  Imaging of adrenal masses. , 1997, The Urologic clinics of North America.

[22]  A M Aisen,et al.  Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. , 1995, Radiology.

[23]  J. Singer,et al.  MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors. , 1995, AJR. American journal of roentgenology.